Teleflex study shows Arrowg+ard-protected central venous catheters cut CLABSI hazard 70% vs plain lines

• Teleflex flagged a newly published peer-reviewed study linking Arrowg+ard-protected central venous catheters to fewer bloodstream infections versus standard catheters.
• Results were published in the American Journal of Infection Control, not slated for a future conference presentation in the release.
• Study also indicated lower mortality for patients using the impregnated catheters despite longer time on the line.
• Readout supports broader adoption of antiseptic-impregnated catheters in higher-risk settings where infection rates remain elevated.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teleflex Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260929569121) on September 29, 2026, and is solely responsible for the information contained therein.